Clearstead Advisors’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.44K | Hold |
481
| – | – | ﹤0.01% | 2137 |
|
|
2025
Q1 | $4.13K | Hold |
481
| – | – | ﹤0.01% | 1778 |
|
|
2024
Q4 | $5.17K | Hold |
481
| – | – | ﹤0.01% | 1711 |
|
|
2024
Q3 | $2.73K | Hold |
481
| – | – | ﹤0.01% | 1803 |
|
|
2024
Q2 | $2.03K | Hold |
481
| – | – | ﹤0.01% | 1814 |
|
|
2024
Q1 | $1.92K | Hold |
481
| – | – | ﹤0.01% | 1319 |
|
|
2023
Q4 | $4.48K | Sell |
481
-481
| -50% | -$4.48K | ﹤0.01% | 1174 |
|
|
2023
Q3 | $6.3K | Buy |
962
+481
| +100% | +$3.15K | ﹤0.01% | 1188 |
|
|
2023
Q2 | $3.91K | Hold |
481
| – | – | ﹤0.01% | 1073 |
|
|
2023
Q1 | $4.12K | Hold |
481
| – | – | ﹤0.01% | 1041 |
|
|
2022
Q4 | $4.45K | Hold |
481
| – | – | ﹤0.01% | 997 |
|
|
2022
Q3 | $5K | Hold |
481
| – | – | ﹤0.01% | 966 |
|
|
2022
Q2 | $5K | Hold |
481
| – | – | ﹤0.01% | 992 |
|
|
2022
Q1 | $6K | Hold |
481
| – | – | ﹤0.01% | 1048 |
|
|
2021
Q4 | $8K | Hold |
481
| – | – | ﹤0.01% | 940 |
|
|
2021
Q3 | $9K | Hold |
481
| – | – | ﹤0.01% | 951 |
|
|
2021
Q2 | $11K | Hold |
481
| – | – | ﹤0.01% | 783 |
|
|
2021
Q1 | $7K | Buy |
+481
| New | +$7K | ﹤0.01% | 823 |
|